Leap Therapeutics, Inc is a biotechnology business based in the US. Leap Therapeutics shares (LPTX) are listed on the NASDAQ and all prices are listed in US Dollars. Leap Therapeutics employs 30 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Leap Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LPTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Leap Therapeutics stock price (NASDAQ: LPTX)Use our graph to track the performance of LPTX stocks over time.
Leap Therapeutics shares at a glance
|Latest market close||$1.62|
|52-week range||$1.33 - $3.24|
|50-day moving average||$1.61|
|200-day moving average||$1.97|
|Wall St. target price||$4.80|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.66|
Buy Leap Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Leap Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Leap Therapeutics price performance over time
|1 week (2021-07-14)||N/A|
|1 month (2021-06-25)||-4.71%|
|3 months (2021-04-21)||N/A|
|6 months (2021-01-21)||N/A|
|1 year (2020-07-21)||N/A|
|2 years (2019-07-21)||N/A|
|3 years (2018-07-21)||N/A|
|5 years (2016-07-21)||N/A|
Is Leap Therapeutics under- or over-valued?
Valuing Leap Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Leap Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Leap Therapeutics's PEG ratio
Leap Therapeutics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.75. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Leap Therapeutics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Leap Therapeutics financials
|Revenue TTM||$1.5 million|
|Gross profit TTM||$1.5 million|
|Return on assets TTM||-52.17%|
|Return on equity TTM||-104.42%|
|Market capitalisation||$87.1 million|
TTM: trailing 12 months
Shorting Leap Therapeutics shares
There are currently 1.3 million Leap Therapeutics shares held short by investors – that's known as Leap Therapeutics's "short interest". This figure is 2.7% up from 1.2 million last month.
There are a few different ways that this level of interest in shorting Leap Therapeutics shares can be evaluated.
Leap Therapeutics's "short interest ratio" (SIR)
Leap Therapeutics's "short interest ratio" (SIR) is the quantity of Leap Therapeutics shares currently shorted divided by the average quantity of Leap Therapeutics shares traded daily (recently around 359634.75783476). Leap Therapeutics's SIR currently stands at 3.51. In other words for every 100,000 Leap Therapeutics shares traded daily on the market, roughly 3510 shares are currently held short.
However Leap Therapeutics's short interest can also be evaluated against the total number of Leap Therapeutics shares, or, against the total number of tradable Leap Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Leap Therapeutics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Leap Therapeutics shares in existence, roughly 20 shares are currently held short) or 0.0393% of the tradable shares (for every 100,000 tradable Leap Therapeutics shares, roughly 39 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Leap Therapeutics.
Find out more about how you can short Leap Therapeutics stock.
Leap Therapeutics share dividends
We're not expecting Leap Therapeutics to pay a dividend over the next 12 months.
Leap Therapeutics share price volatility
Over the last 12 months, Leap Therapeutics's shares have ranged in value from as little as $1.33 up to $3.24. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Leap Therapeutics's is 1.2231. This would suggest that Leap Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Leap Therapeutics overview
Leap Therapeutics, Inc. , a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in multiple clinical trials for treating esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, and prostate cancer. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc.
Stocks similar to Leap Therapeutics
Leap Therapeutics in the news
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Down 19.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Leap Therapeutics, Inc. (LPTX)
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Frequently asked questionsWhat percentage of Leap Therapeutics is owned by insiders or institutions?
Currently 12.612% of Leap Therapeutics shares are held by insiders and 50.475% by institutions. How many people work for Leap Therapeutics?
Latest data suggests 30 work at Leap Therapeutics. When does the fiscal year end for Leap Therapeutics?
Leap Therapeutics's fiscal year ends in December. Where is Leap Therapeutics based?
Leap Therapeutics's address is: 47 Thorndike Street, Cambridge, MA, United States, 02141 What is Leap Therapeutics's ISIN number?
Leap Therapeutics's international securities identification number is: US52187K1016 What is Leap Therapeutics's CUSIP number?
Leap Therapeutics's Committee on Uniform Securities Identification Procedures number is: 52187K101
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert